RightFit Trial Directory

Leukemia clinical trials in Memphis, TN

15 recruiting leukemia studies with a site in Memphis, TN.

All trials in Memphis, TN · All Leukemia trials

RecruitingPhase 2NCT06317662

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Sponsor: National Cancer Institute (NCI)

Knoxville, TN · Memphis, TN · Nashville, TN · +112 more sites

RecruitingPhase 2NCT05554393

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Sponsor: National Cancer Institute (NCI)

Collierville, TN · Knoxville, TN · Memphis, TN · +172 more sites

RecruitingPhase 2NCT06317649

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Sponsor: National Cancer Institute (NCI)

Collierville, TN · Knoxville, TN · Memphis, TN · +222 more sites

RecruitingPhase 3NCT07007312

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Sponsor: Kura Oncology, Inc.

Memphis, TN · Nashville, TN · +41 more sites

RecruitingPhase 1NCT06810583

A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia

Sponsor: St. Jude Children's Research Hospital

Memphis, TN

RecruitingPhase 1NCT04881240

Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

Sponsor: St. Jude Children's Research Hospital

Memphis, TN

RecruitingPhase 1NCT07257419

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

Sponsor: St. Jude Children's Research Hospital

Memphis, TN

RecruitingPhase 1 / Phase 2NCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Sponsor: PedAL BCU, LLC

Knoxville, TN · Memphis, TN · Nashville, TN · +161 more sites

RecruitingPhase not listedNCT05702645

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

Sponsor: Children's Oncology Group

Knoxville, TN · Memphis, TN · Nashville, TN · +69 more sites

RecruitingPhase 1NCT06247787

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

Sponsor: Children's Oncology Group

Memphis, TN · +18 more sites

RecruitingPhase 1NCT04318678

CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)

Sponsor: St. Jude Children's Research Hospital

Memphis, TN

RecruitingPhase 1NCT05101551

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

Sponsor: Norman J. Lacayo

Memphis, TN · +8 more sites

RecruitingPhase 1 / Phase 2NCT04329728

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Sponsor: AVM Biotechnology Inc

Memphis, TN · +10 more sites

RecruitingPhase 1NCT06326463

CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies

Sponsor: St. Jude Children's Research Hospital

Memphis, TN

RecruitingPhase 2NCT05194397

Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors

Sponsor: Children's Hospital of Philadelphia

Memphis, TN · +2 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.